Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
10.28
-0.04 (-0.39%)
At close: Dec 11, 2024, 4:00 PM
10.18
-0.10 (-0.97%)
After-hours: Dec 11, 2024, 7:49 PM EST
Cybin Market Cap
Cybin has a market cap or net worth of $205.61 million as of December 12, 2024. Its market cap has decreased by -1.59% in one year.
Market Cap
205.61M
Enterprise Value
91.48M
1-Year Change
-1.59%
Ranking
Category
Stock Price
$10.28
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $205.61M, an increase of 125.71%. That is a compound annual growth rate of 22.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2024 | 205.61M | 21.94% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 212.63M |
| Ventyx Biosciences | 212.34M |
| Kyverna Therapeutics | 211.33M |
| Acrivon Therapeutics | 209.55M |
| Biomea Fusion | 208.73M |
| Amarin Corporation | 207.77M |
| Accuray | 207.67M |
| Nutex Health | 207.26M |